Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Zhi Liu

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
Molecular Cancer Therapeutics|October 8, 2015
Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal CarcinomaWei Jiang, Na Liu, Xiao-Zhong Chen, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|August 12, 2014
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinomaWen-Hui Chen, Lin-Quan Tang, Feng-Wei Wang, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
BMJ (Clinical Research Ed.)|March 31, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trialShun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagingLin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
Molecular Cancer Therapeutics|October 8, 2015
Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal CarcinomaWei Jiang, Na Liu, Xiao-Zhong Chen, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trialShan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|August 12, 2014
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinomaWen-Hui Chen, Lin-Quan Tang, Feng-Wei Wang, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
BMJ (Clinical Research Ed.)|March 31, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trialShun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagingLin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.
Pageof 20